The Patent Finder
US

Amniotic Membrane Preparations and Purified Compositions and Therapy for Scar Reversal and Inhibition

US 9,161,955 Term ended
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Jun 7, 2024 (U.S. Bank Trust Company, National Association).

Term ended Sep 27, 2026 · High confidence

Filed Mar 13, 2013 as application 13/802,359 · Granted Oct 20, 2015
Base term plus 169 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
Term ended Sep 27, 2026
2006 2026
Clock starts
Sep 27, 2006
Term ended
Sep 27, 2026
Granted
Oct 20, 2015
base term after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
169
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,182,840, US 8,440,235.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 169 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 27, 2006, when application 11/528,902, the earliest non-provisional in its chain, was filed (this one was filed Mar 13, 2013)Sep 27, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+169 days, USPTO patent term adjustment recordMar 15, 2027High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,182,840, US 8,440,235)capped to Sep 27, 2026High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderSep 27, 2026High confidence

This family

US 8,182,840In force
Dec 2028
Dec 2028
US 8,440,235Term ended
Sep 2026
Sep 2026
US 9,161,955this patent
Sep 2026
Sep 2026
US 9,724,370Term ended
Sep 2026
Sep 2026
US 10,272,119Term ended
Sep 2026
Sep 2026
US 10,632,155Lapsed on the fee record
Apr 2024
Apr 2024
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 16, 2013
Reel 30227, frame 457
Tseng, Scheffer; He, Hua; Li, WeiBio-Tissue, Inc.Assignment of Assignor's Interest
Apr 16, 2013
Reel 30227, frame 537
Bio-Tissue, Inc.Tissue Tech, Inc.Assignment of Assignor's Interest
Sep 1, 2015
Reel 36517, frame 977
Bio-Tissue, Inc.Tissuetech, Inc.Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 030227 Frame: 0537. Assignor(S) Hereby Confirms the Assignment.
May 18, 2022
Reel 60116, frame 413
Tissuetech, Inc.; Bio-Tissue, Inc.; Amniox Medical, Inc.Midcap Financial TrustIntellectual Property Security Agreement - Term Loan
May 18, 2022
Reel 60116, frame 468
Tissuetech, Inc.; Bio-Tissue, Inc.; Amniox Medical, Inc.Midcap Funding IV TrustIntellectual Property Security Agreement - Revolving Loan
May 22, 2023
Reel 63713, frame 329
Tissuetech, Inc.Biotissue Holdings Inc.Change of Name
Jun 7, 2024
reel/frame not recorded
Midcap Financial TrustBiotissue Holdings Inc. (F/K/A Tissue Tech, Inc.)Release of Security Interest
Jun 7, 2024
reel/frame not recorded
Midcap Financial TrustBiotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.)Release of Security Interest
Jun 7, 2024
reel/frame not recorded
Midcap Financial TrustBiotissue Surgical Inc. (F/K/A Amniox Medical, Inc.)Release of Security Interest
Jun 7, 2024
reel/frame not recorded
Midcap Funding IV TrustBiotissue Holdings Inc. (F/K/A Tissue Tech, Inc.)Release of Security Interest
Jun 7, 2024
reel/frame not recorded
Midcap Funding IV TrustBiotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.)Release of Security Interest
Jun 7, 2024
reel/frame not recorded
Midcap Funding IV TrustBiotissue Surgical Inc. (F/K/A Amniox Medical, Inc.)Release of Security Interest
Jun 7, 2024
Reel 67666, frame 235
Biotissue Holdings Inc.; Biotissue Ocular Inc.; Biotissue Surgical Inc.U.S. Bank Trust Company, National AssociationSecurity Interest
Jun 7, 2024
Reel 67666, frame 165
Midcap Financial TrustBiotissue Holdings Inc. (F/K/A Tissue Tech, Inc.); Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.); Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.)Release of Security Interest
Jun 7, 2024
Reel 67666, frame 200
Midcap Funding IV TrustBiotissue Holdings Inc. (F/K/A Tissue Tech, Inc.); Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.); Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.)Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited